Mycenax Biotech Market Cap

Mycenax Biotech has a market cap or net worth of 8.19 billion as of June 13, 2025. Its market cap has decreased by -10.09% in one year.

Market Cap

8.19B

Enterprise Value

8.90B

Revenue

725.45M

Ranking

n/a

PE Ratio

n/a

Stock Price

39.10

Market Cap Chart

Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 8.19B, an increase of 1,301.30%. That is a compound annual growth rate of 17.21%.

Market Cap History

Date	Market Cap	% Change
Jun 12, 2025	8.19B	-8.72%
Dec 31, 2024	8.97B	22.00%
Dec 29, 2023	7.35B	-4.53%
Dec 30, 2022	7.70B	32.48%
Dec 30, 2021	5.81B	40.74%
Dec 31, 2020	4.13B	38.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	181.96B
Caliway Biopharmaceuticals	154.45B
Bora Pharmaceuticals Co., LTD.	83.79B
Lotus Pharmaceutical	58.50B
Polaris Group	33.59B
Oneness Biotech	33.29B
Lumosa Therapeutics	28.19B
Center Laboratories	27.49B

Market Cap Rankings